| Year |
Citation |
Score |
| 2019 |
Calabretta P, Hodges HL, Kraft MB, Marando V, Kiessling LL. Bacterial cell wall modification with a glycolipid substrate. Journal of the American Chemical Society. PMID 31081628 DOI: 10.1021/Jacs.9B02290 |
0.376 |
|
| 2015 |
Kedei N, Kraft MB, Keck GE, Herald CL, Melody N, Pettit GR, Blumberg PM. Neristatin 1 provides critical insight into bryostatin 1 structure-function relationships. Journal of Natural Products. 78: 896-900. PMID 25808573 DOI: 10.1021/Acs.Jnatprod.5B00094 |
0.545 |
|
| 2014 |
Kraft MB, Poudel YB, Kedei N, Lewin NE, Peach ML, Blumberg PM, Keck GE. Synthesis of a des-B-ring bryostatin analogue leads to an unexpected ring expansion of the bryolactone core. Journal of the American Chemical Society. 136: 13202-8. PMID 25207434 DOI: 10.1021/Ja5078188 |
0.754 |
|
| 2013 |
Kiessling LL, Kraft MB. Chemistry. A path to complex carbohydrates. Science (New York, N.Y.). 341: 357-8. PMID 23888030 DOI: 10.1126/Science.1241788 |
0.366 |
|
| 2013 |
Kraft MB, Martinez Farias MA, Kiessling LL. Synthesis of lipid-linked arabinofuranose donors for glycosyltransferases. The Journal of Organic Chemistry. 78: 2128-33. PMID 23373821 DOI: 10.1021/Jo302507P |
0.31 |
|
| 2013 |
Kedei N, Telek A, Michalowski AM, Kraft MB, Li W, Poudel YB, Rudra A, Petersen ME, Keck GE, Blumberg PM. Comparison of transcriptional response to phorbol ester, bryostatin 1, and bryostatin analogs in LNCaP and U937 cancer cell lines provides insight into their differential mechanism of action. Biochemical Pharmacology. 85: 313-24. PMID 23146662 DOI: 10.1016/J.Bcp.2012.10.028 |
0.705 |
|
| 2012 |
Kedei N, Telek A, Michalowski AM, Kraft MB, Li W, Poudel YB, Rudra A, Petersen ME, Keck GE, Blumberg PM. Abstract 3815: Comparison of transcriptional response to phorbol ester, bryostatin 1, and bryostatin analogues in LNCaP and U937 cancer cell lines provides insight into their differential mechanism of action Cancer Research. 72: 3815-3815. DOI: 10.1158/1538-7445.Am2012-3815 |
0.706 |
|
| 2011 |
Kedei N, Lubart E, Lewin NE, Telek A, Lim L, Mannan P, Garfield SH, Kraft MB, Keck GE, Kolusheva S, Jelinek R, Blumberg PM. Some phorbol esters might partially resemble bryostatin 1 in their actions on LNCaP prostate cancer cells and U937 leukemia cells. Chembiochem : a European Journal of Chemical Biology. 12: 1242-51. PMID 21542090 DOI: 10.1002/Cbic.201100064 |
0.651 |
|
| 2011 |
Kedei N, Telek A, Czap A, Lubart ES, Czifra G, Yang D, Chen J, Morrison T, Goldsmith PK, Lim L, Mannan P, Garfield SH, Kraft MB, Li W, Keck GE, et al. The synthetic bryostatin analog Merle 23 dissects distinct mechanisms of bryostatin activity in the LNCaP human prostate cancer cell line. Biochemical Pharmacology. 81: 1296-308. PMID 21458422 DOI: 10.1016/J.Bcp.2011.03.018 |
0.69 |
|
| 2009 |
Keck GE, Li W, Kraft MB, Kedei N, Lewin NE, Blumberg PM. The bryostatin 1 A-ring acetate is not the critical determinant for antagonism of phorbol ester-induced biological responses. Organic Letters. 11: 2277-80. PMID 19419164 DOI: 10.1021/Ol900585T |
0.732 |
|
| 2009 |
Keck GE, Poudel YB, Welch DS, Kraft MB, Truong AP, Stephens JC, Kedei N, Lewin NE, Blumberg PM. Substitution on the A-ring confers to bryopyran analogues the unique biological activity characteristic of bryostatins and distinct from that of the phorbol esters. Organic Letters. 11: 593-6. PMID 19113896 DOI: 10.1021/Ol8027253 |
0.652 |
|
| 2008 |
Keck GE, Giles RL, Cee VJ, Wager CA, Yu T, Kraft MB. Total synthesis of epothilones B and D: stannane equivalents for beta-keto ester dianions. The Journal of Organic Chemistry. 73: 9675-91. PMID 18991385 DOI: 10.1021/Jo802215V |
0.641 |
|
| 2008 |
Keck GE, Kraft MB, Truong AP, Li W, Sanchez CC, Kedei N, Lewin NE, Blumberg PM. Convergent assembly of highly potent analogues of bryostatin 1 via pyran annulation: bryostatin look-alikes that mimic phorbol ester function. Journal of the American Chemical Society. 130: 6660-1. PMID 18452293 DOI: 10.1021/Ja8022169 |
0.754 |
|
| Show low-probability matches. |